Number of patients potentially eligible for proton therapy
(2005) In Acta Oncologica 44(8). p.836-849- Abstract
- A group of Swedish radiation oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy in a facility where one of the principal aims is to facilitate randomized and other studies in which the advantage of protons can be shown and the magnitude of the differences compared with optimally administered conventional radiation treatment, also including intensity-modulated radiation therapy (IMRT) and brachytherapy, can be shown. The estimations have been based on current statistics of tumour incidence in Sweden, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response... (More)
- A group of Swedish radiation oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy in a facility where one of the principal aims is to facilitate randomized and other studies in which the advantage of protons can be shown and the magnitude of the differences compared with optimally administered conventional radiation treatment, also including intensity-modulated radiation therapy (IMRT) and brachytherapy, can be shown. The estimations have been based on current statistics of tumour incidence in Sweden, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response relations of different tumours together with information on normal tissue complication rates. In Sweden, it is assessed that between 2200 and 2500 patients annually are eligible for proton beam therapy, and that for these patients the potential therapeutic benefit is so great as to justify the additional expense of proton therapy. This constitutes between 14- 15% of all irradiated patients annually. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/211259
- author
- Glimelius, B ; Ask, Anders LU ; Bjelkengren, Göran LU ; Bjork-Eriksson, T ; Blomquist, E ; Johansson, B ; Karlsson, M and Zackrisson, B
- organization
- publishing date
- 2005
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Acta Oncologica
- volume
- 44
- issue
- 8
- pages
- 836 - 849
- publisher
- Taylor & Francis
- external identifiers
-
- wos:000233855500007
- pmid:16332591
- scopus:28844435764
- ISSN
- 1651-226X
- DOI
- 10.1080/02841860500361049
- language
- English
- LU publication?
- yes
- id
- aba4695f-e4f4-4f99-a136-718e233c3e00 (old id 211259)
- date added to LUP
- 2016-04-01 17:07:09
- date last changed
- 2022-05-01 02:03:58
@article{aba4695f-e4f4-4f99-a136-718e233c3e00,
abstract = {{A group of Swedish radiation oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy in a facility where one of the principal aims is to facilitate randomized and other studies in which the advantage of protons can be shown and the magnitude of the differences compared with optimally administered conventional radiation treatment, also including intensity-modulated radiation therapy (IMRT) and brachytherapy, can be shown. The estimations have been based on current statistics of tumour incidence in Sweden, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response relations of different tumours together with information on normal tissue complication rates. In Sweden, it is assessed that between 2200 and 2500 patients annually are eligible for proton beam therapy, and that for these patients the potential therapeutic benefit is so great as to justify the additional expense of proton therapy. This constitutes between 14- 15% of all irradiated patients annually.}},
author = {{Glimelius, B and Ask, Anders and Bjelkengren, Göran and Bjork-Eriksson, T and Blomquist, E and Johansson, B and Karlsson, M and Zackrisson, B}},
issn = {{1651-226X}},
language = {{eng}},
number = {{8}},
pages = {{836--849}},
publisher = {{Taylor & Francis}},
series = {{Acta Oncologica}},
title = {{Number of patients potentially eligible for proton therapy}},
url = {{http://dx.doi.org/10.1080/02841860500361049}},
doi = {{10.1080/02841860500361049}},
volume = {{44}},
year = {{2005}},
}